Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from TFI International

Benzinga's Top Ratings Upgrades, Downgrades For October 4, 2022

Expert Ratings for TFI International

Expert Ratings for TFI International

Over the past 3 months, 6 analysts have published their opinion on TFI International (NYSE:TFII) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Where TFI International Stands With Analysts

Where TFI International Stands With Analysts

Within the last quarter, TFI International (NYSE:TFII) has observed the following analyst ratings:

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

5 Value Stocks To Watch In The Industrials Sector

What is a Value Stock?

Where TFI International Stands With Analysts

Within the last quarter, TFI International (NYSE:TFII) has observed the following analyst ratings:

What 5 Analyst Ratings Have To Say About TFI International

Within the last quarter, TFI International (NYSE:TFII) has observed the following analyst ratings:

A Preview Of TFI International's Earnings

TFI International (NYSE:TFII) is set to give its latest quarterly earnings report on Thursday, 2022-04-28. Here's what investors need to know before the announcement. Analysts estimate that TFI International will report an earnings per share (EPS) of $1.23.

inkl

Read news from The Economist, FT, and more,
with one subscription

IBD Stock Of The Day: TFII Stock Is In Buy Range As Supply-Chain Issues Drive Trucking Stocks

IBD Stock Of The Day: TFII Stock Is In Buy Range As Supply-Chain Issues Drive Trucking Stocks

TFI International is Stock Of The Day. The Canadian trucking company is in buy range as it rebounded from its 50-day and broke a trendline.

Investors Business Daily

Organisations

Paramount Global

Gilead Sciences

Core Scientific

Bank of New York Mellon

B.Riley Securities

Ginkgo Bioworks Holdings

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play